RA
ETRM

Royce & Associates’s EnteroMedics Inc. ETRM Stock Holding History

Royce & Associates’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-618
Closed -$798K – 1463
2014
Q3 		$798K Sell
618
-392
-39% -$575K ﹤0.01% 1157
2014
Q2 		$1.65M Sell
1,010
-214
-17% -$400K ﹤0.01% 1072
2014
Q1 		$2.34M Hold
1,224
– – 0.01% 1025
2013
Q4 		$2.62M Buy
1,224
+1,191
+3,609% +$1.92M 0.01% 1018
2013
Q3 		$44K Sell
33
-15
-31% -$17.5K ﹤0.01% 1407
2013
Q2 		$57K Buy
+48
New +$50.7K ﹤0.01% 1372

Other funds holding ETRM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $133M AUM 48.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
B
Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return
VAM
Visium Asset Management New York $955M AUM 3.58% 1-Year Est. Return
JGC
J. Goldman & Co New York $2.16B AUM 33.8% 1-Year Est. Return